Fund HoldingsFlagship Pioneering Inc.

Total Portfolio Value
$1.38B
Total Bought
$35.12M
Total Sold
$693.33M
Net Transaction
-$658.21M
Filing Period:
Securities
SharesValue ($K)
Q2 2023
Q3 2023
Change
Q2 2023
Q3 2023
Weight (%)
Change
Evelo Biosciences Inc2,521,3697,932,624+5,411,2558,19431,0962.26%+22,901
Axcella Health Inc01,170,059+1,170,059012,2150.89%+12,215
Syros Pharmaceuticals Inc993,848993,84803,1313,9260.28%+795
Axcella Health Inc29,251,5450-29,251,5456,3860-6,386
Sigilon Therapeutics Inc797,7200-797,72017,9570-17,957
Denali Therapeutics Inc(DNLI)2,619,9682,619,968077,31554,0503.92%-23,265
Foghorn Therapeutics Inc12,674,12012,674,120089,22663,3714.60%-25,855
Seres Therapeutics Inc23,117,04523,117,0450110,73155,0193.99%-55,712
Omega Therapeutics Inc29,225,57929,225,5790163,66362,8354.56%-100,828
Sana Biotechnology Inc(SANA)33,290,01825,001,856-8,288,162198,40996,7577.02%-101,651
Moderna Inc(MRNA)12,886,7439,666,038-3,220,7051,565,739998,40572.47%-567,334
Page 1 of 1